伤口、缺血和足部感染评分在外周动脉疾病患者中的实际应用
基于2016至2022年大型全州协作数据,17,417例慢性肢体威胁性缺血患者中83.4%记录了WIfI分期,分期越高1年死亡率、30天和1年截肢率越高,未记录WIfI评分者死亡和截肢率更高。
要点
- 83.4%的慢性肢体威胁性缺血患者记录了WIfI分期。
- WIfI分期从1升至4,1年死亡率从12%升至21%(P < .001)。
- WIfI分期从1升至4,30天截肢率从5%升至38%、1年截肢率从15%升至55%(P < .001)。
核心结论
- SVS WIfI临床分期与下肢血运重建后慢性肢体威胁性缺血患者的1年截肢率显著相关。
- 近55%的4期患者在介入后1年内需要大截肢,该研究支持将WIfI分类系统用于慢性肢体威胁性缺血患者的临床决策。
研究设计与样本
- 使用大型全州协作数据,识别2016年至2022年间接受开放手术血运重建或外周血管介入的慢性肢体威胁性缺血患者。
- 共纳入17,417例患者,主要暴露为术前临床WIfI分期,按SVS下肢威胁肢体分类系统分为临床WIfI 1、2、3或4期。
- 主要结局为30天和1年截肢率与死亡率,采用多变量逻辑回归估计WIfI分期与血运重建后结局的关联。
主要发现
- 17,417例患者中83.4%(n = 14,529)记录了WIfI分期;57.6%接受外周血管介入,42.4%接受开放手术血运重建。
- 49.5%为1期,19.3%为2期,12.8%为3期,18.3%符合4期标准。
- 3期和4期患者糖尿病、充血性心力衰竭和肾衰竭发生率更高,当前或既往吸烟者比例更低。
- 3期患者中一半接受开放手术血运重建,1期患者最常接受外周血管介入(64%)。
- WIfI分期从1升至4,1年死亡率从12%升至21%(P < .001),30天截肢率从5%升至38%(P < .001),1年截肢率从15%升至55%(P < .001)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Society for Vascular Surgery (SVS) Wound, Ischemia, and foot Infection (WIfI) classification system aims to risk stratify patients with chronic limb-threatening ischemia (CLTI), predicting both amputation rates and the need for revascularization. However, real-world use of the system and whether it predicts outcomes accurately after open revascularization and peripheral interventions is unclear. Therefore, we sought to determine the adoption of the WIfI classification system within a contemporary statewide collaborative as well as the impact of patient factor, and WIfI risk assessment on short- and long-term outcomes. METHODS: Using data from a large statewide collaborative, we identified patients with CLTI undergoing open surgical revascularization or peripheral vascular intervention (PVI) between 2016 and 2022. The primary exposure was preoperative clinical WIfI stage. Patients were categorized according to the SVS Lower Extremity Threatened Limb Classification System into clinical WIfI stages 1, 2, 3, or 4. The primary outcomes were 30-day and 1-year amputation and mortality rates. Multivariable logistic regression was performed to estimate the association of WIfI stage on postrevascularization outcomes. RESULTS: In the cohort of 17,417 patients, 83.4% (n = 14,529) had WIfI stage documented. PVIs were performed on 57.6% of patients, and 42.4% underwent an open surgical revascularization. Of the patients, 49.5% were classified as stage 1, 19.3% stage 2, 12.8% stage 3, and 18.3% of patients met stage 4 criteria. Stage 3 and 4 patients had higher rates of diabetes, congestive heart failure, and renal failure, and were less likely to be current or former smokers. One-half of stage 3 patients underwent open surgical revascularization, whereas stage 1 patients were most likely to have received a PVI (64%). As WIfI stage increased from 1 to 4, 1-year mortality increased from 12% to 21% (P < .001), 30-day amputation rates increased from 5% to 38% (P < .001), and 1-year amputation rates increased from 15% to 55% (P < .001). Finally, patients who did not have WIfI scores classified had significantly higher 30-day and 1-year mortality rates, as well as higher 30-day and 1-year amputation rates. CONCLUSIONS: The SVS WIfI clinical stage is significantly associated with 1-year amputation rates in patients with CLTI after lower extremity revascularization. Because nearly 55% of stage 4 patients require a major amputation within 1 year of intervention, this finding study supports use of the WIfI classification system in clinical decision-making for patients with CLTI.
引用
- Smith ME, Braet DJ, Albright J, et al. Real-world application of Wound, Ischemia, and foot Infection scores in peripheral arterial disease patients. J Vasc Surg. 2024. PMID: 38723913. doi:10.1016/j.jvs.2024.04.071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。